fbpx

American Society of Hematology (ASH) Annual Meeting 2020

The All-Virtual 62nd Annual Society of Hematology Annual Meeting & Exposition is scheduled for December 2-11, 2020. The conference will feature research findings about many hematologic conditions, including chronic lymphocytic leukemia (CLL). Visit the ASH annual meeting website for more details.

Anti-BCMA CAR T-Cell Therapy CT103A Provides Rapid, Durable Responses

In a single-arm phase I/II study, infusion with CT103A, a novel fully human B-cell maturation antigen (BCMA)-targeted chimeric antigen...
T cell attacking a cancer cell

Tisa-Cel Found Noninferior to Standard of Care in Relapsed/Refractory Aggressive B-Cell NHL

  According to results from the phase III BELINDA trial, patients with relapsed/refractory aggressive B-cell non-Hodgkin lymphoma (NHL) who received...

ZUMA-7: Benefits of Axi-Cel Persist Over Current Standard of Care in Aggressive B-Cell Lymphoma

The chimeric antigen receptor (CAR) T-cell therapy axicabtagene ciloleucel (axi-cel) demonstrated significant and clinically meaningful improvement in event-free survival...
Advertisement

Hematology and Oncology News

Curated Journal Abstracts

Advertisement
Advertisement